Treatment of trichomonal vaginitis with single dose tinidazole (Fasigyn).
A new trichomonacidal agent, Tinidazole, (Fasigyn) has been used in a single oral dose of 2 g in 24 patients with very good results. An over-all cure rate of 100% (6 patients) was achieved in in-patients and of 94% 23 out of 24 patients in out-patients. The failures may be attributed to recurrence due to concomitant bacterial infection or to re-infection by a male partner. This regime is therefore strongly recommended as the treatment of choice for Trichomonal vaginalis infection.
D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D009593:Nitroimidazoles / Q000627:therapeutic use*; D011247:Pregnancy; D014011:Tinidazole / Q000009:adverse effects / Q000627:therapeutic use*; D014247:Trichomonas Vaginitis / Q000188:drug therapy* / Q000382:microbiology
D009593:Nitroimidazoles; D014011:Tinidazole